Form 4: W.K. Kellogg Foundation Trust Executes Pre-Planned Sale of Kellanova Shares

The W.K. Kellogg Foundation Trust, a significant 10% owner and director of Kellanova, reported the sale of 114,583 shares of common stock on June 16, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• The W.K. Kellogg Foundation Trust, identified as a 10% owner and director of Kellanova (ticker: K), reported a transaction on June 16, 2025.
• The transaction involved the sale of 114,583 shares of Kellanova common stock.
• The shares were sold at a price of $80.1903 per share.
• Following this transaction, the W.K. Kellogg Foundation Trust beneficially owns 46,243,284 shares of Kellanova common stock.
• The sale was executed pursuant to trading instructions given by the Trust on May 7, 2024, which are intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, indicating a pre-planned sale.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can be perceived negatively, the fact that it was conducted under a pre-planned Rule 10b5-1 program mitigates concerns that it's based on adverse new information, making it a routine disclosure.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, which indicates a pre-arranged sale not based on new, non-public information, thereby reducing the potential negative signal of an insider sale.

Negatives

• The W.K. Kellogg Foundation Trust, a significant shareholder and director, reduced its direct beneficial ownership in Kellanova by selling 114,583 shares.

Risks

• No specific risks were detailed in this Form 4 filing beyond the inherent market risks associated with holding equity securities.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding Kellanova's future performance or strategic direction.

Management Comments

• The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Industry Context

This Form 4 filing reports an insider transaction and does not provide broader industry context or trends. It reflects a specific ownership adjustment by a major shareholder.

Stakeholder Impact

• Shareholders: The sale by a significant 10% owner and director could be viewed as a slight negative signal, but its execution under a 10b5-1 plan suggests it's not indicative of a change in the company's fundamental outlook. The overall impact on the broader shareholder base is likely minimal given the pre-planned nature.

Key Dates

Keywords

Kellanova, W.K. Kellogg Foundation Trust, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Equity Securities, Beneficial Ownership, SEC Filing